The first home health station to deliver cardiac, vascular, and metabolic analysis with expanded longevity insights—available in real time on a redesigned HD handle display, with DEXA-level body composition correlation.
HD Handle Display • Higher-Precision Body Composition • Longevity Scan • Blood Pressure Insights • SpO2 • CES 2026 Innovation Award Honoree
BOSTON, July 15, 2026 /PRNewswire/ -- Withings, the pioneer in connected health and inventor of the first connected scale, today announced that Withings BodyScan 2 ($599.95) is now available in the United States and is FSA/HSA eligible. Measurements are displayed in real time on an ultra-readable color screen embedded in the handle, empowering individuals to better understand their health and extend their healthy years—one measurement at a time.

"BodyScan 2 provides a comprehensive assessment of cardiovascular and metabolic health. Our goal is simple: help people and their physicians move from reactive healthcare to truly preventive care—enabling earlier intervention, better health decisions, and ultimately extending healthy years of life for millions." — Eric Carreel, Chairman and Co-founder, Withings
Two Tailored Scans: A Daily Habit and a Weekly Longevity Assessment
BodyScan 2 adapts to everyday life with two complementary scans—one designed for daily monitoring, the other for a deeper weekly assessment of long-term health and longevity.
Together, the Daily Scan and Weekly Longevity Scan transform a growing set of cardiovascular, metabolic, vascular, and neurological biomarkers into a continuous picture of long-term health. By tracking how the body evolves mechanically, metabolically, and vascularly over time, BodyScan 2 empowers individuals and their physicians to detect changes earlier, make more informed decisions, and support healthier aging.
Precision Body Architecture: Professional-Grade 6-Zone Body Composition
BodyScan 2 uses a proprietary 13-frequency Bioimpedance Spectroscopy (BIS) system to deliver independent fat mass and muscle mass readings for each of 6 body segments: right arm, left arm, trunk, right leg, left leg, and core.
Metabolic Wellness
BodyScan 2 measures a unique set of metabolic indicators that go beyond what traditional scales typically track - nerve response, visceral fat, and glucose resilience - to help users better understand how their daily habits influence their overall metabolic wellness over time. Whether pursuing weight management goals, navigating GLP-1 treatments, or simply wanting to understand how lifestyle choices shape overall wellness, BodyScan 2 helps users monitor meaningful changes over time.
Cardiovascular Health
BodyScan 2 combines ECG2, ICG, and PPG technology to help you track your heart health, understand what it means, and make early lifestyle changes that support a longer, healthier life.
Design, Withings+, and Availability
Designed in France, BodyScan 2 completes a full scan in 90 seconds on a single tempered-glass surface with 8 ITO-embedded electrodes and 4 stainless steel electrodes in a retractable handle with a bright HD color screen. Battery life runs up to 15 months per charge.
Every BodyScan 2 includes a complimentary one-month trial of Withings+5 ($9.95/month or $99.50/year), which unlocks advanced health scores including Heart Age and Glucose Resilience3, an AI Health Assistant, personalized trend analysis, and a Lifetime Guarantee.
Withings BodyScan 2 is available starting July 15, 2026 at withings.com in the US for $599.95.
About Withings
A pioneer in real-life health monitoring, Withings created the first connected scale in 2009 and has continually innovated to offer an ecosystem of clinically validated connected health devices, used by over 15 million people worldwide and by numerous renowned healthcare centers and research institutes. The Withings ecosystem measures over 90 biomarkers. Your body already knows. Withings helps you hear it. Visit withings.com.
Press Contact
Alex McKechnie
alex.mckechnie@12080group.com
475.399.4056
1Internal comparative study between Withings BodyScan measurements and DEXA scan results. 99% correlation observed on fat mass results. Individual results may vary. BodyScan 2 is not a medical device for diagnostic purposes.
2The 6-lead ECG and atrial fibrillation (AFib) detection features are medically regulated. These features are enabled in BodyScan 2 by Withings Scan Monitor 2.0, the FDA-cleared software (510(k) K230812) that powers ECG and AFib detection on the device — the clearance applies to this software, not to the BodyScan 2 hardware itself. All other features described are intended to support general wellness and are not intended for the diagnosis, treatment, cure, mitigation, or prevention of any disease.
3Glucose Resilience is intended for general wellness and fitness purposes and is not intended to diagnose, treat, cure, or prevent any disease. Feature rolls out in the Withings+ app before end of 2026. BodyScan 2's weight, body composition, and related wellness metrics are not intended to diagnose, treat, cure, or prevent any disease and are not a substitute for professional medical advice. Always consult a qualified healthcare professional regarding your health.
5Subject to Withings terms and conditions, available at: https://www.withings.com/us/en/legal/services-terms-and-conditions
6Based on an internal comparison as of June 2026 between BodyScan 2's 13 bioelectrical frequencies against six consumer smart scales priced under $200 in the US with an average of 2 frequencies.
7Neeland IJ et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. The Lancet Diabetes & Endocrinology, 2019. Gastaldelli A. Role of visceral fat in insulin resistance and type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases, 2022.Associations of Different Adipose Tissue Depots with Insulin Resistance: A Systematic Review and Meta-analysis of Observational Studies. PMID: 26686961.
About Abbott's Lingo Continuous Glucose Monitor: The Lingo Glucose System is intended for users 18 years and older not on insulin. It is not intended for diagnosis of diseases, including diabetes. The Lingo program does not guarantee that everyone will achieve the same results as individual responses may vary. Consult your healthcare professional before making changes to your diet or exercise regimen or if you have an eating disorder or a history of eating disorders. For more information, visit www.hellolingo.com.
Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or understood through the use of this device.

View original content to download multimedia:https://www.prnewswire.com/news-releases/withings-bodyscan-2-now-available-in-the-us-setting-a-standard-in-preventive-health-and-longevity-monitoring-302825384.html
SOURCE Withings